Page 35 - P4403.59-V61_Numark Pharmacy Magazine Mar 25 PRINT 2_Neat
P. 35
What is a Pharmacy Liaison 3. Link actions to root causes
Form? If your investigation identifies
contributing factors (e.g.,
The PLF is similar to NHS Datix or similar-looking products stored
Significant Event Analysis (SEA) together), detail the corrective
forms and is sent as part of the measures taken, such as
GPhC’s triage process. reorganizing storage or adding
It provides a summary of the warning labels.
incident, including details about your 4. Keep a record
pharmacy (e.g., registration number, Retain a copy of the completed
superintendent pharmacist name) form and supporting
and any relevant dates. documentation in line with your
The GPhC typically sends pharmacy’s data retention policy.
these forms via email to the Need Support?
Superintendent Pharmacist or
another designated contact. We’re here to help!
Responses are generally requested If you’re unsure about completing
within one week, so acknowledging the form or require guidance, our
receipt promptly is good practice. Numark Information Services team
If you anticipate delays (e.g., due to is happy to help. They can provide
annual leave), inform the GPhC early advice and support to ensure your
to manage expectations. response is both accurate and
Top tips for completing a comprehensive.
GPhC PLF Contact the team
Acknowledge the request promptly information.services@numark-
Respond to the email upon receipt, central.co.uk
quoting the unique case reference Remember, receiving a PLF doesn’t
number included in the form. have to be overwhelming. With the
1. Gather the necessary details right approach and support, you
Review the incident summary can handle it with confidence and
provided. professionalism.
If the information is unclear or
incomplete, don’t hesitate to
request additional details from
the GPhC caseworker. They can
contact the person who raised
the concern if needed.
2. Provide a comprehensive
response
Include all relevant details about
the incident, actions taken, and
any changes implemented to
reduce the risk of recurrence.
Be mindful that your response
may be shared (in part) with the
person who reported the concern.
35
07/02/2025 11:52:47
P4403.59-V61_Numark Pharmacy Magazine Mar 25.indd 35
P4403.59-V61_Numark Pharmacy Magazine Mar 25.indd 35 07/02/2025 11:52:47
